Oncolytics Biotech (R) Announces Study to Investigate Combination of Pelareorep and Avelumab in Metastatic Breast Cancer in Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer

Stock Information for Oncolytics Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.